Department of Electrical and Electronics Engineering, METU, Ankara, Turkey.
METU MEMS Research and Application Center, Ankara, Turkey.
Mikrochim Acta. 2024 Apr 2;191(5):229. doi: 10.1007/s00604-024-06315-2.
The growing interest in microfluidic biosensors has led to improvements in the analytical performance of various sensing mechanisms. Although various sensors can be integrated with microfluidics, electrochemical ones have been most commonly employed due to their ease of miniaturization, integration ability, and low cost, making them an established point-of-care diagnostic method. This concept can be easily adapted to the detection of biomarkers specific to certain cancer types. Pathological profiling of hepatocellular carcinoma (HCC) is heterogeneous and rather complex, and biopsy samples contain limited information regarding the tumor and do not reflect its heterogeneity. Circulating tumor DNAs (ctDNAs), which can contain information regarding cancer characteristics, have been studied tremendously since liquid biopsy emerged as a new diagnostic method. Recent improvements in the accuracy and sensitivity of ctDNA determination also paved the way for genotyping of somatic genomic alterations. In this study, three-electrode (Au-Pt-Ag) glass chips were fabricated and combined with polydimethylsiloxane (PDMS) microchannels to establish an electrochemical microfluidic sensor for detecting c.747G > T hotspot mutations in the TP53 gene of ctDNAs from HCC. The preparation and analysis times of the constructed sensor were as short as 2 h in total, and a relatively high flow rate of 30 µl/min was used during immobilization and hybridization steps. To the best of our knowledge, this is the first time a PDMS-based microfluidic electrochemical sensor has been developed to target HCC ctDNAs. The system exhibited a limit of detection (LOD) of 24.1 fM within the tested range of 2-200 fM. The sensor demonstrated high specificity in tests conducted with fully noncomplementary and one-base mismatched target sequences. The developed platform is promising for detecting HCC-specific ctDNA at very low concentrations without requiring pre-enrichment steps.
对微流控生物传感器的日益关注导致各种传感机制的分析性能得到改善。尽管各种传感器都可以与微流控技术集成,但由于其易于小型化、集成能力和低成本,电化学传感器是最常用的,使其成为一种既定的即时诊断方法。这一概念可以很容易地应用于检测特定癌症类型的生物标志物。肝细胞癌(HCC)的病理分析具有异质性和复杂性,活检样本中包含的肿瘤信息有限,不能反映其异质性。循环肿瘤 DNA(ctDNA)可以包含有关癌症特征的信息,自从液体活检作为一种新的诊断方法出现以来,它就受到了极大的研究关注。最近,ctDNA 测定的准确性和灵敏度的提高也为体细胞基因组改变的基因分型铺平了道路。在这项研究中,制造了三电极(Au-Pt-Ag)玻璃芯片,并与聚二甲基硅氧烷(PDMS)微通道结合,建立了一种用于检测 HCC 中 ctDNA 中 TP53 基因 c.747G > T 热点突变的电化学微流控传感器。构建传感器的准备和分析时间总共只有 2 小时,在固定化和杂交步骤中使用了相对较高的 30 μl/min 的流速。据我们所知,这是首次开发基于 PDMS 的微流控电化学传感器来针对 HCC ctDNA。该系统在 2-200 fM 的测试范围内的检测限(LOD)为 24.1 fM。在与完全非互补和一个碱基错配靶序列进行的测试中,传感器表现出很高的特异性。该开发平台有望在无需预富集步骤的情况下,以非常低的浓度检测 HCC 特异性 ctDNA。